Figure 5.

Immunological parameters as possible predictive markers for 5FU-based chemotherapy. Immunological parameters measured with immunohistology and FACS analysis of CD3⁺ lymphocytes and effCD8⁺ T cells (Figure 5) were correlated with patients' OS and/or DFS with Kaplan–Meier methods. For statistical data, see Supplementary Table S3.